Rebecca Velez Frey

Direktor/Vorstandsmitglied bei Siduma Therapeutics, Inc.

Health Technology

Consumer Services

Finance

Aktive Positionen von Rebecca Velez Frey

Unternehmen	Position	Beginn	Ende
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Private Equity Investor	01.02.2021	-
Halda Therapeutics LLC Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.	Direktor/Vorstandsmitglied	-	-
	Corporate Officer/Principal	-	-
Siduma Therapeutics, Inc. Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.	Direktor/Vorstandsmitglied	01.12.2021	-
	Vorstandsvorsitzender	01.12.2021	-

Karriereverlauf von Rebecca Velez Frey

Ehemalige bekannte Positionen von Rebecca Velez Frey

Unternehmen	Position	Beginn	Ende
Evolveimmune Therapeutics, Inc. Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.	Geschäftsführer	01.02.2020	31.12.2021
Cardurion Pharmaceuticals LLC Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.	Geschäftsführer	01.01.2018	31.12.2020
ALEXION PHARMACEUTICALS, INC.	Präsident	01.08.2012	30.09.2017
Novartis Inflammasome Research, Inc. Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.	Direktor/Vorstandsmitglied	01.07.2002	30.09.2006

Ausbildung von Rebecca Velez Frey

Northeastern University

Undergraduate Degree

Statistik

International

Vereinigte Staaten

Operativ

Director/Board Member	3
Chief Operating Officer	2
Private Equity Investor	1

Sektoral

Health Technology	6
Consumer Services	2
Finance	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Private Unternehmen	7
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Finance
Cardurion Pharmaceuticals LLC Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.	Health Technology
Novartis Inflammasome Research, Inc. Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.	Health Technology
Halda Therapeutics LLC Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.	Health Services
Evolveimmune Therapeutics, Inc. Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.	Health Technology
Siduma Therapeutics, Inc. Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an